ProfileGDS5678 / 1430237_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 47% 47% 48% 49% 47% 46% 53% 48% 48% 49% 50% 49% 48% 48% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1648547
GSM967853U87-EV human glioblastoma xenograft - Control 23.1075347
GSM967854U87-EV human glioblastoma xenograft - Control 33.1497748
GSM967855U87-EV human glioblastoma xenograft - Control 43.1045549
GSM967856U87-EV human glioblastoma xenograft - Control 53.0455847
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1804346
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.3926353
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1429648
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1219348
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1387249
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1778550
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1240349
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.1340448
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.1215648